Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q4 2025 Earnings Call Transcript January 30, 2026 Regeneron Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $11.44, expectations were ...
"Nurses kept coming by to see him because usually people don't live through his specific type of break. He had to have a halo for a while (think Regina George after the bus), and recovery was not fun, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results